{"id":"CHEMBL105","canonicalSmiles":"CO[C@@]12[C@H](COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1C[C@@H]1N[C@@H]12","inchiKey":"NWIBSHFKIJFRCO-WUDYKRTCSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MITOMYCIN","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Jelmyto","Mitomycin","Mitosol","Mitozytrex","Mutamycin","Mytozytrex"],"synonyms":["Ametycine","Mitocin-c","Mitomycin","Mitomycin c","Mitomycin-c","Muamycin","Mytozytrex","NSC-26980","UGN-101","UGN-102","Ugn-102"],"crossReferences":{"DailyMed":["mitomycin"],"PubChem":["144205046","170464814","57260126","87663"],"Wikipedia":["Mitomycin"],"drugbank":["DB00305"],"chEBI":["27504"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and has 4 approved and 40 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1077","canonicalSmiles":"Nc1c(CC(=O)O)cccc1C(=O)c1ccc(Br)cc1","inchiKey":"ZBPLOVFIXSTCRZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BROMFENAC","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Saudi Arabia"," United States"],"classes":["Hepatotoxicity"," Misuse"],"year":1998},"tradeNames":["Yellox"],"synonyms":["Bromfenac","ISV-303"],"crossReferences":{"DailyMed":["bromfenac%20sodium"],"PubChem":["26757971"],"Wikipedia":["Bromfenac"],"drugbank":["DB00963"],"chEBI":["240107"]},"childChemblIds":["CHEMBL751","CHEMBL3181947"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["MONDO_0001330","MP_0001845","MONDO_0003005","HP_0200026","EFO_0001365","EFO_1000906","MONDO_0005129","EFO_0007141","EFO_0009321","EFO_0005752"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and has 4 approved and 6 investigational indications. It was withdrawn in Saudi Arabia and  United States initially in 1998 due to Hepatotoxicity and  Misuse."}
{"id":"CHEMBL1080884","canonicalSmiles":"Fc1ccc(OC[C@@H]2CNCCO2)c2c1CCC2","inchiKey":"HTODIQZHVCHVGM-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LUBAZODONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lubazodone","YM-35992"],"crossReferences":{"drugbank":["DB09196"]},"childChemblIds":["CHEMBL1822892"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1095280","canonicalSmiles":"Nc1ncnc2c1ncn2C[C@@H](O)[C@@H](O)C(=O)O","inchiKey":"LIEMBEWXEZJEEZ-INEUFUBQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERITADENINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Eritadenine"],"crossReferences":{"drugbank":["DB03769"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1159650","canonicalSmiles":"CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C","inchiKey":"CBGUOGMQLZIXBE-XGQKBEPLSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CLOBETASOL PROPIONATE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Clarelux","Clobaderm","Clobetasol propionate","Clobetasol propionate (emollient)","Clobex","Cormax","Dermovate","Dermovate nn","Embeline","Embeline e","Etrivex","Impeklo","Impoyz","Olux","Olux e","Temovate","Temovate e"],"synonyms":["CCI 4725","CCI-4725","Clobecort amex","Clobetasol","Clobetasol 17-propionate","Clobetasol propionate","Dovate","GR 2/925","NSC-758634","Psorex"],"crossReferences":{"DailyMed":["clobetasol%20propionate"],"PubChem":["144204967","170465385","56422175","855884"],"Wikipedia":["Clobetasol_propionate"],"drugbank":["DB01013"],"chEBI":["31414"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["MONDO_0013730","EFO_0000685","EFO_1001494","EFO_1001395","EFO_1000724","EFO_1000764","EFO_0000701","EFO_1000657","EFO_0000274","EFO_1000706","EFO_1000623","EFO_0007187","EFO_1001347","EFO_0004192","Orphanet_79364","MONDO_0005129","MONDO_0002406","EFO_0000676","EFO_1001993","EFO_1000766","EFO_1000726","EFO_0008517","EFO_0004775","EFO_1001949"],"count":24},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and has 3 approved and 17 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1189","canonicalSmiles":"CCNCC","inchiKey":"HPNMFZURTQLUMO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIETHYLAMINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diethyl-Amine","Diethylamine"],"crossReferences":{"PubChem":["144209704","17389600"],"Wikipedia":["Diethylamine"],"chEBI":["85259"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1200323","canonicalSmiles":"CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1.Cl","inchiKey":"WQVZLXWQESQGIF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LABETALOL HYDROCHLORIDE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL429","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Labetalol Hydrocloride","Labetalol hydrochloride","Labetalol hydrochloride in dextrose","Labetalol hydrochloride in sodium chloride","Labrocol","Normodyne","Trandate"],"synonyms":["AH 5158A","AH-5158A","AH-5158A HYDROCHLORIDE","Ibidomide hydrochloride","Labetalol hcl","Labetalol hydrochloride","NSC-290312","SCH 15719W","SCH-15719W","SCH-15719W HYDROCHLORIDE"],"crossReferences":{"DailyMed":["labetalol%20hydrochloride"],"PubChem":["144204174","144213042","26747550","50106500","56422413","855542"]},"linkedTargets":{"rows":["ENSG00000274286","ENSG00000184160","ENSG00000169252","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000043591","ENSG00000188778","ENSG00000150594"],"count":9},"linkedDiseases":{"rows":["EFO_0005669","EFO_0000668","EFO_0000537"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and is indicated for hypertension and has 2 investigational indications."}
{"id":"CHEMBL1200616","canonicalSmiles":"NS(=O)(=O)c1cc2c(cc1Cl)N=C[N-]S2(=O)=O.[Na+]","inchiKey":"CPIWHAFLBZQYLQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLOROTHIAZIDE SODIUM","yearOfFirstApproval":1958,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL842","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Chlorothiazide sodium","Diuril"],"synonyms":["Chlorothiazide sodium","Chlorothiazide sodium salt"],"crossReferences":{"DailyMed":["chlorothiazide%20sodium"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1958."}
{"id":"CHEMBL1200721","canonicalSmiles":"C[C@]12CC[C@@H]3c4ccc(OC(=O)N(CCCl)CCCl)cc4CC[C@H]3[C@@H]1CC[C@@H]2OP(=O)([O-])[O-].[Na+].[Na+]","inchiKey":"IIUMCNJTGSMNRO-VVSKJQCTSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"ESTRAMUSTINE PHOSPHATE SODIUM","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1756","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Emcyt"],"synonyms":["Estramustine 17-(dihydrogenphosphate) disodium salt anhydrous","Estramustine 17-(dihydrogenphosphate) disodium salt monohydrate","Estramustine phosphate sodium","Estramustine phosphate sodium hydrate","Estramustine phosphate sodium monohydrate","Estramustine sodium phosphate","RO 21-8837/001","RO-218837-001"],"crossReferences":{"DailyMed":["estramustine%20phosphate%20sodium"],"PubChem":["144206926"],"chEBI":["31562"]},"linkedTargets":{"rows":["ENSG00000140009"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000673","EFO_0000574","MONDO_0007254","EFO_0000313","MONDO_0002367","MONDO_0008315"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and is indicated for carcinoma and neoplasm and has 5 investigational indications."}
{"id":"CHEMBL1200751","canonicalSmiles":"O.Sc1ncnc2nc[nH]c12","inchiKey":"WFFQYWAAEWLHJC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MERCAPTOPURINE","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1425","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mercaptopurine","Puri-nethol","Purinethol","Purixan","Xaluprine"],"synonyms":["6-mercaptopurine","6-mercaptopurine monohydrate","Mercaptopurine","Mercaptopurine anhydrous","Mercaptopurine hydrate","Mercaptopurinum","NSC-755","NSC-759614"],"crossReferences":{"PubChem":["103804943","57260342"],"chEBI":["31822"]},"linkedTargets":{"rows":["ENSG00000128059"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","MONDO_0000873","EFO_0000209","MONDO_0003541","EFO_0000565","EFO_1000318","EFO_1001935","MONDO_0003268","MONDO_0019460","EFO_0004289","EFO_0000330","EFO_0002499","MONDO_0020743","EFO_0000094","EFO_0010580","EFO_0000616","EFO_0000220","MONDO_0000870","EFO_0000222","EFO_1001946","EFO_0002501","EFO_0000224","EFO_0000384","MONDO_0044917","EFO_1001936","EFO_1001947","EFO_0000574","MONDO_0024880","EFO_0003833","EFO_0000519","EFO_0003872"],"count":31},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1953 and has 4 approved and 18 investigational indications."}
{"id":"CHEMBL1201147","canonicalSmiles":"CCCCC(CC)COC(=O)C(C#N)=C(c1ccccc1)c1ccccc1","inchiKey":"FMJSMJQBSVNSBF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OCTOCRYLENE","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["NSC-760433","Octocrilene","Octocrylene"],"crossReferences":{"PubChem":["144204704","144207434","170464719","17389332","29215118","85147156"],"Wikipedia":["Octocrylene"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2006 and is indicated for freckles."}
{"id":"CHEMBL1201148","canonicalSmiles":"C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3C(=O)C[C@]2(C)[C@@]1(O)C(=O)CO","inchiKey":"PIDANAQULIKBQS-RNUIGHNZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEPREDNISONE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Betapar"],"synonyms":["Meprednisone","NSC-527579","SCH 4358","SCH-4358"],"crossReferences":{"PubChem":["144207161","170465165"],"Wikipedia":["Meprednisone"],"drugbank":["DB09383"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0000756"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and has 1 investigational indication."}
{"id":"CHEMBL1201474","drugType":"Unknown","blackBoxWarning":false,"name":"COLESTIPOL HYDROCHLORIDE","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Colestid","Colestid Flavored Colestid","Colestid orange","Colestipol hydrochloride","Flavored colestid"],"synonyms":["Colestipol","Colestipol hcl","Colestipol hydrochloride","NSC-147003"],"crossReferences":{"DailyMed":["colestipol%20hydrochloride"],"DrugCentral":["728"]},"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1977 and is indicated for hypercholesterolemia and has 5 investigational indications."}
{"id":"CHEMBL1201831","drugType":"Antibody","blackBoxWarning":true,"name":"CERTOLIZUMAB PEGOL","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cimzia"],"synonyms":["CDP 870","CDP-870","CDP870","Certolizumab pegol","PHA-738144"],"crossReferences":{"DailyMed":["certolizumab%20pegol"],"DrugCentral":["4968"],"Wikipedia":["Certolizumab_pegol"]},"linkedTargets":{"rows":["ENSG00000232810"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","MP_0001845","EFO_0000685","Orphanet_247353","EFO_0000756","EFO_0003898","EFO_0003778","EFO_0000676","EFO_1000869","EFO_0000540","EFO_0000384","EFO_0002609"],"count":12},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and has 6 approved and 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1230658","canonicalSmiles":"CCCCCNC(=O)[C@H](Cc1ccc(N(C(=O)C(=O)O)c2ccccc2C(=O)O)c2ccccc12)NC(C)=O","inchiKey":"UESXELNYBIOROE-QHCPKHFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230658","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01820"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233097","canonicalSmiles":"N=C(N)c1ccc(NC(=O)Nc2ccc(Oc3ccccc3)cc2)cc1","inchiKey":"ZHCAYBOLUMAUQX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1233097","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03337"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234089","canonicalSmiles":"N=C(N)NS(=O)(=O)c1ccc(N/C=C2\\C(=O)Nc3ccccc32)cc1","inchiKey":"DMCRNUMVSATRTP-LCYFTJDESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234089","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08126"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234283","canonicalSmiles":"CO[C@H]1O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]1O","inchiKey":"OHWCAVRRXKJCRB-XUVCUMPTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234283","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03194"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235429","canonicalSmiles":"CC(=O)O[C@@]12[C@H](O)[C@@H](C)[C@@]3(O)[C@@H](C=C(CO)C[C@]4(O)C(=O)C(C)=C[C@@H]34)[C@@H]1C2(C)C","inchiKey":"SDSVJYOOAPRSDA-RPCQODIISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"13-Acetylphorbol","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["13-Acetylphorbol"],"crossReferences":{"drugbank":["DB04376"],"chEBI":["45127"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235735","canonicalSmiles":"O=C(CC1(S(=O)(=O)c2ccc(Oc3ccccc3)cc2)CCOCC1)NO","inchiKey":"ARIRIZBKMKMEBD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235735","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08491"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1256696","canonicalSmiles":"CCN(CC)CCOCCOC(=O)C1(c2ccccc2)CCCC1.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"AKJDEXBCRLOVTH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBETAPENTANE CITRATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL73234","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"]},"tradeNames":["Toclase"],"synonyms":["Carbetapentane citrate","Loucarbate","NSC-757833","Pentoxyverine","Pentoxyverine citrate","Pentoxyverine hydrogen citrate"],"crossReferences":{"PubChem":["11112007","11113006","124881868","26747484","26747485","46500452","50106075","85231297","85273776"]},"linkedTargets":{"rows":["ENSG00000147955"],"count":1},"linkedDiseases":{"rows":["EFO_0007486"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for sinusitis. It was withdrawn in United States."}
{"id":"CHEMBL132767","canonicalSmiles":"CCN(CC)c1cc(C)nc2ncnn12","inchiKey":"GSNOZLZNQMLSKJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRAPIDIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AR 12008","AR-12008","Rocornal","Trapidil","Trapymin"],"crossReferences":{"PubChem":["11112623","14745540","170465770","50086436"],"drugbank":["DB09283"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL13376","canonicalSmiles":"COc1ccc2c(C(=O)c3ccc(Cl)cc3)c(C)n(CC(=O)O)c2c1","inchiKey":"DGMZLCLHHVYDIS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOMETACIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["France"],"classes":["Hepatotoxicity"],"year":1987},"tradeNames":[],"synonyms":["C 1656","C-1656","Clometacin","Mindolic acid","R 3959","R-3959"],"crossReferences":{"PubChem":["144206860"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in France  in 1987 due to Hepatotoxicity."}
{"id":"CHEMBL1472830","canonicalSmiles":"CS(=O)(=O)NC(=O)CCC/C=C\\C[C@H]1C(=O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)COc1ccccc1","inchiKey":"UQZVCDCIMBLVNR-TWYODKAFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULPROSTONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-34,089","CP-34089","Sulprostone","ZK 57 671","ZK-57671"],"crossReferences":{"PubChem":["29217657"],"drugbank":["DB12708"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1472989","canonicalSmiles":"CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1.CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1.O=C(O)/C=C/C(=O)O","inchiKey":"VMDFASMUILANOL-WXXKFALUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BISOPROLOL FUMARATE","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL645","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bipranix","Bisoprolol fumarate","Cardicor","Concor","Congescor","Emcor","Emcor ls","Isoten mitis","Monocor","Soloc","Soprol","Vivacor","Zebeta"],"synonyms":["Bisoprolol fumarate","Bisoprolol hemifumarate","CL 297,939","CL-297939","Detensiel","EMD-33-512","EMD-33512","Emconcor","Euradal","Isoten","Speridol"],"crossReferences":{"DailyMed":["bisoprolol%20fumarate"],"PubChem":["144204814","144206959","170464815","26753629"],"chEBI":["3128"]},"linkedTargets":{"rows":["ENSG00000043591"],"count":1},"linkedDiseases":{"rows":["Orphanet_98896","MONDO_0001134","Orphanet_79292","EFO_0000537"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and is indicated for hypertension and has 2 investigational indications."}
{"id":"CHEMBL1499","canonicalSmiles":"C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO","inchiKey":"MFYSYFVPBJMHGN-ZPOLXVRWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1499","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144205092","144211757","170466316","26751583","50104218","50104219","50104220","56422112","75082","855981","90341612"],"drugbank":["DB14681"],"chEBI":["16962"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1593906","canonicalSmiles":"CCC(=O)O[C@@](Cc1ccccc1)(c1ccccc1)[C@@H](C)CN(C)C.O=S(=O)(O)c1ccc2ccccc2c1","inchiKey":"VZPXFHVJUUSVLH-VNJAQMQMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVOPROPOXYPHENE NAPSYLATE","yearOfFirstApproval":1962,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1738990","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Novrad"],"synonyms":["29866","LILLY 29866","LILLY-29866","LY-29866","Levopropoxyphene napsilate","Levopropoxyphene napsylate","Levopropoxyphene napsylate anhydrous"],"crossReferences":{"PubChem":["11112964","144204309"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1962."}
{"id":"CHEMBL1726","canonicalSmiles":"COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-]","inchiKey":"VKQFCGNPDRICFG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NISOLDIPINE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nisoldipine","Sular","Syscor mr 10","Syscor mr 20","Syscor mr 30"],"synonyms":["BAY K 5552","BAY-K-5552","Baymycard","Geomatrix 16e","NSC-759106","Nisoldipin","Nisoldipine","Nisoldipine (stn)"],"crossReferences":{"DailyMed":["nisoldipine"],"PubChem":["144205804","144212682","170465320","26758055"],"Wikipedia":["Nisoldipine"],"drugbank":["DB00401"],"chEBI":["76917"]},"linkedTargets":{"rows":["ENSG00000157388","ENSG00000081248","ENSG00000102001","ENSG00000151067"],"count":4},"linkedDiseases":{"rows":["EFO_0000401","EFO_0000319","EFO_0000537"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and is indicated for hypertension and cardiovascular disease."}
{"id":"CHEMBL1743059","drugType":"Antibody","blackBoxWarning":false,"name":"RACOTUMOMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Racotumomab"],"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL184412","canonicalSmiles":"CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCN(CCCC)CCCC)cc1","inchiKey":"ZQTNQVWKHCQYLQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DRONEDARONE","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dronedarone","SR-33589","SR33589"],"crossReferences":{"DailyMed":["dronedarone%20hydrochloride"],"PubChem":["144206559","170465064"],"Wikipedia":["Dronedarone"],"drugbank":["DB04855"],"chEBI":["50659"]},"childChemblIds":["CHEMBL1201729"],"linkedTargets":{"rows":["ENSG00000136546","ENSG00000157388","ENSG00000151067","ENSG00000123700","ENSG00000168356","ENSG00000007314","ENSG00000196876","ENSG00000185313","ENSG00000183873","ENSG00000081248","ENSG00000102001","ENSG00000144285","ENSG00000169432","ENSG00000138622","ENSG00000136531","ENSG00000153253"],"count":16},"linkedDiseases":{"rows":["EFO_0003911","EFO_0000275","EFO_0004269","EFO_0000373"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and is indicated for cardiac arrhythmia and atrial fibrillation and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL186483","canonicalSmiles":"CS(=O)(=O)c1ccc(C(=N)N)cc1","inchiKey":"ANPBNAUKOUYEGJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-Methanesulfonyl-Benzamidine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-Methanesulfonyl-Benzamidine"],"crossReferences":{"drugbank":["DB07368"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1887147","canonicalSmiles":"CS(=O)(=O)c1cc(C(F)(F)F)ccc1C(=O)c1cnoc1C1CC1","inchiKey":"OYIKARCXOQLFHF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOXAFLUTOLE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["264-EUP-99","Balance","Isoxaflutole","Merlin","RPA-201772"],"crossReferences":{"PubChem":["144211240","26757421"],"drugbank":["DB12938"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1908333","canonicalSmiles":"CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N(C)C)[C@H]2O)[C@@H](CCN2C[C@@H](C)C[C@@H](C)C2)C[C@@H](C)C(=O)/C=C/C(C)=C/[C@@H]1CO[C@@H]1O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]1OC","inchiKey":"JTSDBFGMPLKDCD-XVFHVFLVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TILMICOSIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Micotil"],"synonyms":["EL-870","EL870","LY-177370","LY177370","NSC-759584","Tilmicosin"],"crossReferences":{"PubChem":["144205099"],"drugbank":["DB11471"]},"childChemblIds":["CHEMBL2105782"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL195450","canonicalSmiles":"O=C(Nc1ccc2[nH]ccc2c1)c1cc(F)cc(N2CCOCC2)c1","inchiKey":"VMLSXFMXUNVCSK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL195450","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08092"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL197550","canonicalSmiles":"O=C(O)c1ccc(Cc2ccccc2Cl)o1","inchiKey":"YRUPEIZURHOLHV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL197550","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07308"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2","canonicalSmiles":"COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC","inchiKey":"IENZQIKPVFGBNW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRAZOSIN","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["CP-12299","CP-122991","Prazosin"],"crossReferences":{"DailyMed":["prazosin%20hydrochloride"],"PubChem":["11112649","11112650","11113367","124882482","124882484","124882486","124882487","144207195","170465415","26751613","26751614","50100502","50104272","50104273","50104274","50104275","90340959"],"Wikipedia":["Prazosin"],"drugbank":["DB00457"],"chEBI":["8364"]},"childChemblIds":["CHEMBL1558","CHEMBL1347191"],"linkedTargets":{"rows":["ENSG00000171873","ENSG00000170214","ENSG00000120907"],"count":3},"linkedDiseases":{"rows":["EFO_0005854","EFO_0004777","HP_0000726","EFO_0003768","EFO_0001358","EFO_0000537","MONDO_0100096","EFO_0004253","EFO_0004701","MONDO_0007079","EFO_0000400","HP_0000011","EFO_0005230","EFO_0005223"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1976 and is indicated for diabetes mellitus and hypertension and has 9 investigational indications."}
{"id":"CHEMBL2104231","canonicalSmiles":"CC(=O)[C@@]1(C)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3CC[C@@]21C","inchiKey":"JWAHBTQSSMYISL-MHTWAQMVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEMEGESTONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Demegestone","NSC-118189","R 2453","R-2453"],"crossReferences":{"drugbank":["DB13857"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104956","canonicalSmiles":"CCCCC(CC)COc1ccc(-c2nc(-c3ccc(OC)cc3)nc(-c3ccc(OCC(CC)CCCC)cc3O)n2)c(O)c1","inchiKey":"XVAMCHGMPYWHNL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BEMOTRIZINOL","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Tinosorb s"],"synonyms":["BEMT","Bemotrizinol","FAT 70'884","FAT-70884","NSC-759870"],"crossReferences":{"drugbank":["DB11206"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105302","canonicalSmiles":"c1ccc(C(Cc2noc(CCN3CCCCC3)n2)c2ccccc2)cc1","inchiKey":"PXZDWASDNFWKSD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRENOXDIAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Prenoxdiazin","Prenoxdiazine"],"crossReferences":{"drugbank":["DB13397"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105661","canonicalSmiles":"CCNCCS(=O)(=O)NC[C@@]1(c2ccccc2)SC(NC(=O)C(C)(C)C)=NN1C(=O)C(C)(C)C","inchiKey":"YVAFBXLHPINSIK-QHCPKHFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LITRONESIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KF 89617","KF-89617","KF89617","LY 2523355","LY-2523355","LY2523355","Litronesib"],"crossReferences":{"drugbank":["DB11861"]},"linkedTargets":{"rows":["ENSG00000138160"],"count":1},"linkedDiseases":{"rows":["EFO_0000565","EFO_0000616","MONDO_0001056","EFO_0006859","MONDO_0008170","EFO_0000702","MONDO_0007254","MONDO_0007576","MONDO_0024880","MONDO_0008315","EFO_0003060","EFO_1001951","EFO_0000311"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 12 investigational indications."}
{"id":"CHEMBL2105683","canonicalSmiles":"COc1ccc2cc([C@H](C)C(=O)OCCS(C)(=O)=O)ccc2c1","inchiKey":"JGBUBSOKFSVXKS-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAPROXEN ETEMESIL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LT-NS001","MX-1094","Naproxen etemesil"],"crossReferences":{"drugbank":["DB12398"]},"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["MONDO_0005178"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2107350","canonicalSmiles":"CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)[C@@H]1c1ccccc1Cl.O=C(O)C[C@H](O)C(=O)O","inchiKey":"ICLGPDCMPQYWIA-OSRSGTIQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVAMLODIPINE MALATE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL2111097","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Levamlodipine l-malate","Levamlodipine malate"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2107360","canonicalSmiles":"CCCCCCCCCCCCCCCC(=O)OC1CCCn2c1nc(C)c(CCN1CCC(c3noc4cc(F)ccc34)CC1)c2=O","inchiKey":"VOMKSBFLAZZBOW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PALIPERIDONE PALMITATE","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Invega sustenna","Invega trinza"],"synonyms":["JNS-010","JNS010","Paliperidone palmitate","Palperidone palmitate","R-092670","R092670","RO-92670","RO92670"],"crossReferences":{"DailyMed":["paliperidone%20palmitate"],"chEBI":["83808"]},"childChemblIds":["CHEMBL4745890"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000102468"],"count":2},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0000289","EFO_0000677","EFO_0005411"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and is indicated for schizoaffective disorder and schizophrenia. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2107448","canonicalSmiles":"CN1CCN(/C=C2\\N=C3CN=C(c4ccccc4Cl)c4cc([N+](=O)[O-])ccc4N3C2=O)CC1","inchiKey":"UTEFBSAVJNEPTR-RGEXLXHISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LOPRAZOLAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Loprazolam","Triazulenone","Triazulenone, (z)-","Triazulenone, (z)-isomer"],"crossReferences":{"drugbank":["DB13643"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107614","canonicalSmiles":"CCOC(=O)[C@@]1(OC(=O)C(Cl)Cl)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C","inchiKey":"QAIOVDNCIZSSSF-RFAJLIJZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETIPREDNOL DICLOACETATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BNP-166","Etiprednol dicloacetate"],"crossReferences":{"drugbank":["DB05442"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2107743","canonicalSmiles":"CC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)CC)[C@@H](C)CC","inchiKey":"ZKGHZWHJOPXFIK-KMICFFLZSA-N","drugType":"Protein","blackBoxWarning":false,"name":"EDRATIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Edratide","TV-4710"],"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2107844","drugType":"Protein","blackBoxWarning":false,"name":"BRIOBACEPT","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BR-3-FC","BR3-FC","Briobacept","SS-79"],"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108167","drugType":"Antibody","blackBoxWarning":false,"name":"VEPALIMOMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Vapantix","Vepalimomab"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2108258","drugType":"Antibody","blackBoxWarning":false,"name":"ATOROLIMUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Atorolimumab"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108791","drugType":"Enzyme","blackBoxWarning":false,"name":"TENECTEPLASE","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Metalyse"],"synonyms":["TNK-TPA","Tenecteplase"],"crossReferences":{"DailyMed":["tenecteplase"],"DrugCentral":["5066"]},"linkedTargets":{"rows":["ENSG00000122194"],"count":1},"linkedDiseases":{"rows":["HP_0002140","EFO_0004278","MONDO_0002679","EFO_1001154","EFO_0000618","EFO_1000637","EFO_0008585","MONDO_0000831","EFO_0003827","EFO_0000712","MONDO_0005299","EFO_0008583","EFO_0000612","HP_0004419","EFO_0009637"],"count":15},"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and has 4 approved and 11 investigational indications."}
{"id":"CHEMBL2109032","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIUM POLYCARBOPHIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Mitrolan","Noveon ca-1","Noveon ca-2","Sorboquel"],"synonyms":["Calcium polycarbophil","Polycarbophil calcium","Polycarbophil, calcium","WI 140","WI-140","WL 140","WL-140"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109255","drugType":"Antibody","blackBoxWarning":false,"name":"HEFI-1","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HEFI-1","Hefi-1"],"linkedTargets":{"rows":["ENSG00000120949"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000574"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109282","drugType":"Antibody","blackBoxWarning":false,"name":"RG-7636","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DEDN-6526A","RG-7636"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109325","drugType":"Antibody","blackBoxWarning":false,"name":"AMG-191","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG-191","Amg-191"],"linkedTargets":{"rows":["ENSG00000157404"],"count":1},"linkedDiseases":{"rows":["Orphanet_183660"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109486","drugType":"Antibody","blackBoxWarning":false,"name":"CDP-850","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CDP-850"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL219544","canonicalSmiles":"Nc1nc2c(c(=O)[nH]1)CC=N2","inchiKey":"LOSIULRWFAEMFL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"7-DEAZAGUANINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02245"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL221245","canonicalSmiles":"CCc1ccc(/C=C2\\SC(N[C@H](C(=O)O)c3ccc(F)cc3)=NC2=O)o1","inchiKey":"RNEACARJKXYVND-MZLJFPOFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL221245","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08706"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL221735","canonicalSmiles":"NCC1CCN(Cc2ccc3[nH]c(-c4cc5ccccc5[nH]c4=O)cc3c2)CC1","inchiKey":"KBIHHEGEALBUMT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL221735","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07025"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2219414","canonicalSmiles":"CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)c(NC(=O)CN5CCCC5)cc(F)c4C[C@H]3C[C@@H]12.Cl.Cl","inchiKey":"JYCNMRVZELJVAW-RZVFYPHASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERAVACYCLINE DIHYDROCHLORIDE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1951095","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Xerava"],"synonyms":["Eravacycline dihydrochloride","TP-434-046","TP434046"],"crossReferences":{"DailyMed":["eravacycline%20dihydrochloride"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2018 and is indicated for infection."}
{"id":"CHEMBL2227975","canonicalSmiles":"Cc1c(COC(=O)[C@@H]2[C@H](/C=C(\\Cl)C(F)(F)F)C2(C)C)cccc1-c1ccccc1","inchiKey":"OMFRMAHOUUJSGP-IRHGGOMRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIFENTHRIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15056"],"chEBI":["3093"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL224867","canonicalSmiles":"C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O)[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@H]1C[C@H]3O","inchiKey":"WBWWGRHZICKQGZ-HZAMXZRMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAUROCHOLIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cholaic acid","Cholic acid taurine conjugate","N-Choloyltaurine","Taurocholic acid"],"crossReferences":{"Wikipedia":["Taurocholic_acid"],"drugbank":["DB04348"],"chEBI":["28865"]},"childChemblIds":["CHEMBL443728","CHEMBL1361792"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2338329","canonicalSmiles":"Cc1nc(C(=O)NCC(=O)O)c(O)c2ccc(Oc3ccccc3)cc12","inchiKey":"YOZBGTLTNGAVFU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROXADUSTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ASP-1517","ASP1517","FG-4592","FG4592","Roxadustat"],"crossReferences":{"PubChem":["174006837"],"drugbank":["DB04847"]},"linkedTargets":{"rows":["ENSG00000135766","ENSG00000178467","ENSG00000129521","ENSG00000269858"],"count":4},"linkedDiseases":{"rows":["EFO_0000198","EFO_0003086","EFO_0008585","EFO_0003884","EFO_0004272"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2348782","canonicalSmiles":"C[C@]12CCC(=O)C=C1CC[C@@H]1C2=CC[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO","inchiKey":"BCFCRXOJOFDUMZ-ONKRVSLGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2348782","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12081"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2354773","drugType":"Small molecule","blackBoxWarning":false,"name":"AUROTHIOGLUCOSE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aureotan 100","Solganal"],"synonyms":["(1-thio-d-glucopyranosato)gold","Aureotan","Aurothioglucose","Aurumine","Authron","Brenol","Glysanol b","Gold thioglucose","NSC-759601","Oronol","Solganal b"],"crossReferences":{"DrugCentral":["4349"],"PubChem":["144205102"]},"linkedTargets":{"rows":["ENSG00000198431"],"count":1},"linkedDiseases":{"rows":["EFO_0005755"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for rheumatic disease."}
{"id":"CHEMBL247378","canonicalSmiles":"O=[N+]([O-])c1cccc2cn[nH]c12","inchiKey":"PQCAUHUKTBHUSA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"7-NITROINDAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["7-Nitroindazole"],"crossReferences":{"PubChem":["11111551","11113328","26746920","50103946","56422885","855595","90340658"],"Wikipedia":["7-Nitroindazole"],"drugbank":["DB02207"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL25028","canonicalSmiles":"CS(C)(=O)=O","inchiKey":"HHVIBTZHLRERCL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHANESULFONYLMETHANE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Methanesulfonylmethane"],"crossReferences":{"PubChem":["251919780","26750007"],"Wikipedia":["Methylsulfonylmethane"],"drugbank":["DB14090"],"chEBI":["9349"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL264950","canonicalSmiles":"O=[N+]([O-])c1ccc(-c2cc[nH]n2)cc1","inchiKey":"IPIYADCDDIUVPS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL264950","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08695"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL267225","canonicalSmiles":"C[C@H]1[C@H](C)CC[C@]2(C)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@@H](O)[C@](C)(C(=O)O)[C@@H]5CC[C@]43C)[C@H]12","inchiKey":"NBGQZFQREPIKMG-PONOSELZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BOSWELLIC ACID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Beta-Boswellic Acid","Boswellic acid"],"crossReferences":{"PubChem":["26725249"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL295829","canonicalSmiles":"COc1ccc2c(c1)c(CC(=O)NO)c(C)n2C(=O)c1ccc(Cl)cc1","inchiKey":"AJRNYCDWNITGHF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXAMETACIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Oxametacin","Oxamethacin"],"crossReferences":{"Wikipedia":["Oxametacin"],"drugbank":["DB13308"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL300891","canonicalSmiles":"Cc1ccccc1CNC(=O)[C@H]1N(C(=O)[C@@H](O)[C@H](Cc2ccccc2)NC(=O)c2cccc(O)c2C)CSC1(C)C","inchiKey":"CUFQBQOBLVLKRF-RZDMPUFOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KNI-764","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KNI-764"],"crossReferences":{"drugbank":["DB02668"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3039524","canonicalSmiles":"Cc1ccc(S(=O)(=O)O)cc1.O=C(Nc1ccc(Cl)c(S(=O)(=O)N2CCNCC2)c1O)Nc1cccc(F)c1Cl","inchiKey":"CJAUWWGOABMMJX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELUBRIXIN TOSYLATE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL2178579","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Elubrixin tosilate","Elubrixin tosylate","SB-656933-AAA"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3182314","canonicalSmiles":"CC(C)(C)C(=O)Oc1ccc(S(=O)(=O)Nc2ccccc2C(=O)NCC(=O)[O-])cc1.O.O.O.O.[Na+]","inchiKey":"PLHREJBSQUSUCW-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SIVELESTAT SODIUM","maximumClinicalTrialPhase":3,"parentId":"CHEMBL76688","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EI-546","Elaspol","LY-544349 SODIUM HYDRATE","LY544349 SODIUM HYDRATE","ONO-5046 SODIUM HYDRATE","ONO-5046.NA","Sivelestat sodium","Sivelestat sodium hydrate","Sivelestat sodium salt tetrahydrate","Sivelestat sodium tetrahydrate"],"crossReferences":{"PubChem":["144206123","170465996"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3184026","canonicalSmiles":"NC(N)=O.OO","inchiKey":"AQLJVWUFPCUVLO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3184026","maximumClinicalTrialPhase":0,"parentId":"CHEMBL985","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144212768"],"drugbank":["DB11129"],"chEBI":["75178"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3187964","canonicalSmiles":"CCC(=O)O[C@]1(c2ccccc2)CCN(C)C[C@H]1C","inchiKey":"UVAZQQHAVMNMHE-CZUORRHYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3187964","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206173"],"drugbank":["DB01473"]},"childChemblIds":["CHEMBL3246683"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL325109","canonicalSmiles":"COc1cc(N)c(Cl)cc1C(=O)NC1CCN(Cc2ccccc2)CC1","inchiKey":"BVPWJMCABCPUQY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLEBOPRIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Clanzoflat","Cleboril"],"synonyms":["Amicos","Clanzol","Clast","Clebopride","Clebopride hydrogen malate","Clebopride malate","Cleprid","LAS 9273","LAS-9273","Motilex"],"crossReferences":{"PubChem":["11112867"],"Wikipedia":["Clebopride"],"drugbank":["DB13511"]},"childChemblIds":["CHEMBL1599248"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000164270"],"count":2},"linkedDiseases":{"rows":["EFO_0010282"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for gastrointestinal disease."}
{"id":"CHEMBL33468","canonicalSmiles":"O=C(O)CCON=C1c2ccccc2-c2ccccc21","inchiKey":"LASWLEUVWJDDBA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL33468","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07240"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3421729","canonicalSmiles":"C[C@H]1c2cccc(CCC(C)(C)O)c2C[C@H](CO)N1C(=O)Cc1c(Cl)cccc1Cl","inchiKey":"XHCSBQBBGNQINS-DOTOQJQBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEVIDALEN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-3154207","LY3154207","Ly3154207","Mevidalen"],"linkedTargets":{"rows":["ENSG00000184845"],"count":1},"linkedDiseases":{"rows":["MONDO_0005180","EFO_0006792"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL346455","canonicalSmiles":"Oc1ccc(CCNc2nc(SCCCc3ccc(Cl)cc3)nc(N3CCNCC3)n2)cc1","inchiKey":"AIBKIFHSQQYXLG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL346455","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04020"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL350775","canonicalSmiles":"COc1cc(C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc2cccnc2)CCCc2cccnc2)cc(OC)c1OC","inchiKey":"CGVWPQOFHSAKRR-NDEPHWFRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIRICODAR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Biricodar"],"crossReferences":{"Wikipedia":["Biricodar"],"drugbank":["DB04851"]},"childChemblIds":["CHEMBL2104406"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL354077","canonicalSmiles":"Nc1ccncc1N","inchiKey":"OYTKINVCDFNREN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMIFAMPRIDINE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ruzurgi"],"synonyms":["3,4-DAP","3,4-Diammoniopyridinium","4-DAP","Amifampridine","DAP","Dynamine","NSC-521760","Pyridine-3,4-Diamine"],"crossReferences":{"DailyMed":["amifampridine","amifampridine%20phosphate"],"PubChem":["144206108","170466846","50112814","51088028","56323425"],"Wikipedia":["3,4-Diaminopyridine"],"drugbank":["DB11640"]},"childChemblIds":["CHEMBL3301611"],"linkedTargets":{"rows":["ENSG00000164794","ENSG00000116396","ENSG00000184408","ENSG00000162975","ENSG00000171126","ENSG00000177272","ENSG00000168263","ENSG00000053918","ENSG00000129159","ENSG00000140015","ENSG00000026559","ENSG00000143105","ENSG00000182674","ENSG00000173826","ENSG00000184156","ENSG00000185760","ENSG00000124134","ENSG00000183960","ENSG00000111262","ENSG00000102057","ENSG00000178342","ENSG00000055118","ENSG00000117013","ENSG00000170745","ENSG00000130037","ENSG00000131398","ENSG00000182255","ENSG00000075043","ENSG00000143473","ENSG00000168418","ENSG00000158445","ENSG00000177301","ENSG00000089558","ENSG00000135519","ENSG00000151079","ENSG00000166006","ENSG00000104848","ENSG00000156486","ENSG00000184611","ENSG00000171385"],"count":40},"linkedDiseases":{"rows":["EFO_0008525","Orphanet_130","MONDO_0005301","EFO_0009851","EFO_0004991","EFO_0005542"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for myasthenia gravis and has 6 investigational indications."}
{"id":"CHEMBL3544991","drugType":"Antibody","blackBoxWarning":false,"name":"DOMAGROZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Domagrozumab","PF-06252616"],"linkedTargets":{"rows":["ENSG00000138379"],"count":1},"linkedDiseases":{"rows":["Orphanet_98896"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545074","drugType":"Small molecule","blackBoxWarning":false,"name":"LEO-15520","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Leo-15520"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545323","drugType":"Small molecule","blackBoxWarning":false,"name":"PWT-33579","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pwt-33579"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3666807","canonicalSmiles":"C[C@H](NC(=O)C(C)(F)F)[C@H](Oc1ccc2c(cnn2-c2cccc(C(=O)N[C@@H]3CCOC3)c2)c1)c1ccc2c(c1)OCCO2","inchiKey":"ZZWJKLGCDHYVMB-BWGXUDETSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VELSECORAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-7594","AZD7594","Azd 7594","Azd7594","Velsecorat"],"childChemblIds":["CHEMBL4093501"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3707246","canonicalSmiles":"CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@@H]4NCCO)no2)cc1C#N.Cl","inchiKey":"HAOOCAKHSFYDBU-BDQAORGHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OZANIMOD HYDROCHLORIDE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3707247","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zeposia"],"synonyms":["Ozanimod hydrochloride","RPC-1063 HCL","RPC1063 HCL"],"crossReferences":{"DailyMed":["ozanimod%20hydrochloride"]},"linkedTargets":{"rows":["ENSG00000170989"],"count":1},"linkedDiseases":{"rows":["MONDO_0005301"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2020 and is indicated for multiple sclerosis."}
{"id":"CHEMBL3707248","canonicalSmiles":"COc1cc2c(cc1OC)[C@H]1C[C@@H](OC(=O)[C@@H](N)C(C)C)[C@H](CC(C)C)CN1CC2.Cc1ccc(S(=O)(=O)O)cc1.Cc1ccc(S(=O)(=O)O)cc1","inchiKey":"BXGKAGLZHGYAMW-TZYFFPFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VALBENAZINE TOSYLATE","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2364639","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ingrezza"],"synonyms":["NBI-98854","Valbenazine ditosylate","Valbenazine tosilate","Valbenazine tosylate"],"crossReferences":{"DailyMed":["valbenazine%20tosylate"]},"linkedTargets":{"rows":["ENSG00000165646"],"count":1},"linkedDiseases":{"rows":["EFO_0004280"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2017 and is indicated for movement disorder."}
{"id":"CHEMBL3707305","drugType":"Small molecule","blackBoxWarning":false,"name":"FERROUS ASCORBATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ascofer","Complefer","Ferrous ascorbate","Iron(ii) ascorbate","J290.062I","L-ascorbic acid, iron complex","Nedifer"],"crossReferences":{"DrugCentral":["4540"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3707365","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"BEMIPARIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bemiparin"],"crossReferences":{"DrugCentral":["4840"]},"linkedTargets":{"rows":["ENSG00000126218"],"count":1},"linkedDiseases":{"rows":["EFO_0001422","HP_0000083","EFO_1001459","EFO_0000702","HP_0004419"],"count":5},"description":"Oligosaccharide drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL375492","canonicalSmiles":"CC(=O)Nc1ccc(/C=N/NC(N)=S)cc1","inchiKey":"SRVJKTDHMYAMHA-WUXMJOGZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMITHIOZONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amithiozone","Citazone","NSC-3550","SQ-2321","TB I-698","Thiacetazone","Thibone","Thioacetazone","Thioacetazonum","Thiocarbazil","Thioparamizone"],"crossReferences":{"PubChem":["144205178","144205179","170466436","26754478","29215319"],"Wikipedia":["Thioacetazone"],"drugbank":["DB12829"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL376505","canonicalSmiles":"CN(C)c1nc2c(Br)c(Br)c(Br)c(Br)c2[nH]1","inchiKey":"SLPJGDQJLTYWCI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL376505","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26753546","26753547","90340899"],"drugbank":["DB04719"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL382127","canonicalSmiles":"NCC1(c2ccccc2)CCCC1","inchiKey":"SJWOFBVBNFLWLP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(1-Phenylcyclopentyl)Methanamine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(1-Phenylcyclopentyl)Methanamine"],"crossReferences":{"drugbank":["DB04577"],"chEBI":["39505"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833333","canonicalSmiles":"C=C(C)[C@@H]1CCC(C)=C[C@H]1c1c(O)cc(CCCCC)cc1O.CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21","inchiKey":"SSNHGLKFJISNTR-DYSNNVSPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NABIXIMOLS","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Sativex"],"synonyms":["Cannabinoids","GW 1000","GW 1000-02","GW-1000","Nabidiolex","Nabiximols","SAB 378","SAB-378","Tetranabinex"],"crossReferences":{"DrugCentral":["4793"],"drugbank":["DB14011"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 13 investigational indications."}
{"id":"CHEMBL3989555","canonicalSmiles":"Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1.Cl.Cl.O","inchiKey":"KDLHYOMCWBWLMM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MECLIZINE HYDROCHLORIDE","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1623","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ancoloxin","Antivert","Meclizine hydrochloride","Sea-legs","Traveleeze"],"synonyms":["Agyrax","Ancolan","Bonamine","Meclizine dihydrochloride monohydrate","Meclizine hcl","Meclizine hydrochloride","Meclizine monohydrochloride","Meclozine dihydrochloride","Meclozine hydrochloride","Meclozine hydrochloride monohydrate","Meclozine monohydrochloride","NSC-28728","NSC-757094","Postafen","UCB-5062"],"crossReferences":{"DailyMed":["meclizine%20hydrochloride"]},"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0006928","HP_0002321","HP_0002017","HP_0002013","HP_0002018"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1957 and has 5 approved indications."}
{"id":"CHEMBL3989767","canonicalSmiles":"CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(N)=O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O","inchiKey":"BBBFJLBPOGFECG-VJVYQDLKSA-N","drugType":"Protein","blackBoxWarning":false,"name":"CALCITONIN SALMON","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Calcimar","Calcitonin-salmon","Miacalcin"],"synonyms":["Calcitonin salmon"],"crossReferences":{"DailyMed":["calcitonin%20salmon"]},"linkedTargets":{"rows":["ENSG00000004948"],"count":1},"linkedDiseases":{"rows":["MONDO_0005277","EFO_0004261","EFO_0003931","EFO_0005687","EFO_0003854","EFO_0003882","EFO_0003843","EFO_0003922","HP_0003072"],"count":9},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1978 and has 3 approved and 2 investigational indications."}
{"id":"CHEMBL4297266","canonicalSmiles":"CCCCC[C@@H](O)/C=C/c1ccccc1/C=C/[C@@H](O)[C@@H](O)CCCC(=O)O","inchiKey":"HEDVTGFTYROYFE-RREUNBNVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BLXA4","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BLXA-4","Benzo-lipoxin a4","Benzo-lxa-4","Benzo-lxa4","Blxa4"],"crossReferences":{"drugbank":["DB12133"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297314","canonicalSmiles":"C1COCN1","inchiKey":"WYNCHZVNFNFDNH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXAZOLIDINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Oxazolidine"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297387","canonicalSmiles":"C[C@@H](c1cc(Cl)cc2ccccc12)N(C)C(=O)CC1(c2ccc(F)cc2)CCN(C)CC1","inchiKey":"DRXBWLBZWAJIEF-IBGZPJMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK-424887","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK424887","Gsk-424887","Gsk424887"],"crossReferences":{"drugbank":["DB12219"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297617","canonicalSmiles":"CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H]2CSSC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N2","inchiKey":"CQXYENUJCPYPTI-LZUXSVOASA-N","drugType":"Protein","blackBoxWarning":false,"name":"MIBENRATIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JNJ-54452840","Jnj-54452840","Mibenratide"],"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297740","drugType":"Protein","blackBoxWarning":false,"name":"DARLEUKIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Darleukin","L19-il2","L19IL2"],"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297936","drugType":"Unknown","blackBoxWarning":false,"name":"RECOMBINANT HUMAN KALLIKREIN-1","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DM-199","DM199","Dm199","Kallikrein-1, recombinant human","Recombinant human kallikrein-1"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297956","drugType":"Unknown","blackBoxWarning":false,"name":"FS-102","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anti-her2 fcab fs102","BMS-986186","FS-102","FS102","Fcab fs102","Fs-102","Fs102"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4298067","drugType":"Antibody","blackBoxWarning":false,"name":"TOMARALIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["OPN-305","Opn 305","Opn-305","Tomaralimab"],"linkedTargets":{"rows":["ENSG00000137462"],"count":1},"linkedDiseases":{"rows":["EFO_0000198"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4298123","drugType":"Antibody","blackBoxWarning":false,"name":"COBOLIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cobolimab","TSR-022","Tsr 022","Tsr-022","WBP-296A"],"linkedTargets":{"rows":["ENSG00000135077"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0002691","EFO_0000756","MONDO_0024880","EFO_0003060"],"count":5},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4594424","canonicalSmiles":"CC(C)C[C@H]1NC(=O)[C@@H](C)N(C)C(=O)[C@H](C2CC2)NC[C@@H](C)Oc2ccccc2CC[C@H](C)NC1=O","inchiKey":"HIIMPSTXUQUYOO-FPJBJBNZSA-N","drugType":"Protein","blackBoxWarning":false,"name":"TZP-102","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TZP-102","Tzp-102"],"linkedTargets":{"rows":["ENSG00000121853"],"count":1},"linkedDiseases":{"rows":["EFO_1000948"],"count":1},"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594432","canonicalSmiles":"CC(C)(O)c1cc(Nc2cc(Oc3cn(C4CC4)nc3C3CCOCC3)ccn2)ccn1","inchiKey":"PNPFMWIDAKQFPY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LY-3200882","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-3200882","LY3200882","Ly-3200882","Ly3200882"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594506","drugType":"Unknown","blackBoxWarning":false,"name":"TERN-101","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-2562175","LY2562175","TERN-101","Tern-101"],"linkedTargets":{"rows":["ENSG00000012504"],"count":1},"linkedDiseases":{"rows":["EFO_1001249"],"count":1},"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594613","drugType":"Unknown","blackBoxWarning":false,"name":"VIS-410","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["VIS410","Vis-410","Vis410"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL477278","canonicalSmiles":"N[C@@H](Cc1ccc(OCC[18F])cc1)C(=O)O","inchiKey":"QZZYPHBVOQMBAT-LRAGLOQXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"O-(2-FLUOROETHYL)-L-TYROSINE F-18","maximumClinicalTrialPhase":2,"parentId":"CHEMBL1908892","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(18f)fluoroethyltyrosine","18f-fet","2-fluoroethyltyrosine f-18","Fet f-18","Fluoroethyl-l-tyrosine (18f)","Fluoroethyltyrosine f-18","J1.857.391A","O-(2-fluoroethyl)-l-tyrosine f-18"],"crossReferences":{"drugbank":["DB15405"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL482968","canonicalSmiles":"Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1","inchiKey":"BLQYVHBZHAISJM-CMDGGOBGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENMD-2076","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ENMD-2076","Enmd 2076","Enmd-2076"],"childChemblIds":["CHEMBL3237191"],"linkedTargets":{"rows":["ENSG00000087586","ENSG00000128052","ENSG00000068078","ENSG00000178999","ENSG00000157404","ENSG00000182578","ENSG00000122025"],"count":7},"linkedDiseases":{"rows":["EFO_0000348","EFO_0001642","MONDO_0008170","EFO_0000182","EFO_1000251","MONDO_0007254","EFO_1001968","EFO_0001378","MONDO_0002087","EFO_0000311"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL534","canonicalSmiles":"CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1","inchiKey":"ZCVMWBYGMWKGHF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KETOTIFEN","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["(R)-Ketotifen","Ketotifen"],"crossReferences":{"DailyMed":["ketotifen%20fumarate"],"PubChem":["104171180","11111350","11111351","11113338","144203727","170465378","26751502","50100258","50104048","90341121"],"Wikipedia":["Ketotifen"],"drugbank":["DB00920"]},"childChemblIds":["CHEMBL1885671","CHEMBL1633"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005687","HP_0012532","EFO_0007425","HP_0001371","MONDO_0005271","EFO_0000274","EFO_0008533","EFO_0003931","MONDO_0100096","MONDO_0002406","EFO_0009521","MONDO_0004979","EFO_0007141","EFO_0005751","EFO_1001417"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and is indicated for eye allergy and allergic disease and has 10 investigational indications."}
{"id":"CHEMBL550495","canonicalSmiles":"CN(C)c1ccc2nc3ccc(=[N+](C)C)cc-3sc2c1.O.O.O.[Cl-]","inchiKey":"XQAXGZLFSSPBMK-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"METHYLENE BLUE","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL191083","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Provayblue","Urolene blue"],"synonyms":["Basic blue 9 trihydrate","C.I. 52015","C.i. basic blue 9 trihydrate","CI 52015","CI-52015","Methylene blue","Methylene blue trihydrate","Methylthionine chloride","Methylthionine hydrochloride","Methylthioninium chloride","NSC-215213","NSC-617593","NSC-759135","Trx0014"],"crossReferences":{"PubChem":["144209723","17388909"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2016 and is indicated for urinary tract infection and has 16 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL559478","canonicalSmiles":"O=C(Oc1ccc(Br)cc1)N1CCN2CCC1CC2","inchiKey":"RXLOZRCLQMJJLC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SSR180711","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["J2.849.107G","SSR-180,711","SSR-180711","SSR180711C","Ssr180711"],"crossReferences":{"PubChem":["144210561"]},"childChemblIds":["CHEMBL3235499"],"linkedTargets":{"rows":["ENSG00000175344"],"count":1},"linkedDiseases":{"rows":["MONDO_0004975"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL608393","canonicalSmiles":"Cn1ccnc1Sc1cc(C(=O)Nc2nccs2)c(N)cc1F","inchiKey":"YUCYMQBDBXVNCE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL608393","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08210"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL6437","canonicalSmiles":"CN1CCN2c3ccccc3Cc3ccccc3C2C1","inchiKey":"UEQUQVLFIPOEMF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIANSERIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["J16.389I","Mianserin","Tolvon"],"crossReferences":{"PubChem":["104171186","124880671","144203742","170465596","26752015","50104682","90341017"],"Wikipedia":["Mianserin"],"drugbank":["DB06148"],"chEBI":["51137"]},"childChemblIds":["CHEMBL544428"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for depressive disorder and unipolar depression and has 3 investigational indications."}
{"id":"CHEMBL647","canonicalSmiles":"Nc1cc(Cl)c(N=C2NCCN2)c(Cl)c1","inchiKey":"IEJXVRYNEISIKR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APRACLONIDINE","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Iopidine"],"synonyms":["Apraclonidine"],"crossReferences":{"DailyMed":["apraclonidine%20hydrochloride"],"PubChem":["11110712","50110931","90341674"],"Wikipedia":["Apraclonidine"],"drugbank":["DB00964"],"chEBI":["2788"]},"childChemblIds":["CHEMBL1200379"],"linkedTargets":{"rows":["ENSG00000184160","ENSG00000274286","ENSG00000150594"],"count":3},"linkedDiseases":{"rows":["EFO_0004991","EFO_0007167","EFO_0000516"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1987 and is indicated for glaucoma."}
{"id":"CHEMBL65061","canonicalSmiles":"CCCCC/C=C\\C[C@@H](O)/C=C/C=C/C=C\\[C@@H](O)CCCC(=O)O","inchiKey":"VNYSSYRCGWBHLG-AMOLWHMGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEUKOTRIENE_B4","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Leukotriene B4"],"crossReferences":{"PubChem":["26754792"],"Wikipedia":["Leukotriene_B4"],"drugbank":["DB12961"],"chEBI":["15647"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL685","canonicalSmiles":"COC(=O)Nc1nc2ccc(C(=O)c3ccccc3)cc2[nH]1","inchiKey":"OPXLLQIJSORQAM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEBENDAZOLE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Emverm","Mebendazole","Mebenvet","Ovex","Telmin","Telmintic","Vermox"],"synonyms":["Chlorfenson","K-6451","Mebendazole","Mebendazole polymorph c","Mebendazolum","NSC-184849","NSC-5618","Orthotran","Ovitelmin","Ovochlor","Pantelmin","R 17,635","R-17635","Vermicidin","Zhihuanqing"],"crossReferences":{"DailyMed":["mebendazole"],"PubChem":["11112718","124882564","144204171","170464914","174007187","26746927","855610"],"Wikipedia":["Mebendazole"],"drugbank":["DB00643"],"chEBI":["6704"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1974 and is indicated for helminthiasis and has 6 investigational indications."}
{"id":"CHEMBL75094","canonicalSmiles":"CC1(C)SCCN(S(=O)(=O)c2ccc(Oc3ccncc3)cc2)[C@H]1C(=O)NO","inchiKey":"YKPYIPVDTNNYCN-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRINOMASTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AG-3340","AG3340","KB-R-9896","Prinomastat"],"crossReferences":{"Wikipedia":["Prinomastat"],"drugbank":["DB05100"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL85943","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM TUNGSTATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Disodium tetraoxatungstate(2-)","Disodium tetraoxotungstate(2-)","Disodium tungstate","Sodium tungstate","Sodium tungstate(vi)","Sodium tungsten oxide (na2wo4)"],"crossReferences":{"chEBI":["63940"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL87647","canonicalSmiles":"Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(CO)c1Br","inchiKey":"LSIZSSASMKSUIU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"R-185545","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["R-185545"],"crossReferences":{"drugbank":["DB06874"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL9225","canonicalSmiles":"CC[C@H](c1ccc(O)cc1)[C@@H](CC)c1ccc(O)cc1","inchiKey":"PBBGSZCBWVPOOL-HDICACEKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MESO-HEXESTROL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hexestrol"],"crossReferences":{"PubChem":["11112224","144203928","144211773","170466031"],"drugbank":["DB07931"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL9519","canonicalSmiles":"O=c1ccn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]1","inchiKey":"QHWZTVCCBMIIKE-SHYZEUOFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL9519","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03413"],"chEBI":["28850"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL95681","canonicalSmiles":"O=C1CCCO1","inchiKey":"YEJRWHAVMIAJKC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTYROLACTONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gama-Butyrolactone"],"crossReferences":{"PubChem":["144207688","144210508"],"Wikipedia":["Gamma-Butyrolactone"],"drugbank":["DB04699"],"chEBI":["42639"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL99203","canonicalSmiles":"Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O","inchiKey":"WHSIXKUPQCKWBY-IOSLPCCCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IODOTUBERCIDIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["5-Iodotubercidine"],"crossReferences":{"drugbank":["DB04604"],"chEBI":["40167"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
